Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer

J. Oto (Valencia, Spain), O. Tura-Ceide (Barcelona, Spain), V. Sánchez-López (Seville, Spain), C. Font (Barcelona, Spain), J. Osorio (Barcelona, Spain), C. Bonjoch (Barcelona, Spain), D. Hervás (Valencia, Spain), E. Arellano (Madrid, Spain), P. Medina (Valencia, Spain), I. Blanco (Barcelona, Spain), V. Peinado (Barcelona, Spain), J. Barberà (Barcelona, Spain), R. Otero (Seville, Spain)

Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Session: Pathogenesis and pathophysiology of pulmonary hypertension
Session type: E-poster
Number: 593

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Oto (Valencia, Spain), O. Tura-Ceide (Barcelona, Spain), V. Sánchez-López (Seville, Spain), C. Font (Barcelona, Spain), J. Osorio (Barcelona, Spain), C. Bonjoch (Barcelona, Spain), D. Hervás (Valencia, Spain), E. Arellano (Madrid, Spain), P. Medina (Valencia, Spain), I. Blanco (Barcelona, Spain), V. Peinado (Barcelona, Spain), J. Barberà (Barcelona, Spain), R. Otero (Seville, Spain). Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer. 593

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018



Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011


Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat
Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017
Year: 2017



Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Source: Eur Respir J, 55 (6) 2000189; 10.1183/13993003.00189-2020
Year: 2020



Circulating microRNA signature and its novel involvement in pathogenesis of chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012

Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

The relationship of thrombus localization with prognosis and chronic tromboembolic pulmonary hypertension in acute pulmonary thromboembolia
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020


The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Prevalence of chronic thromboembolic pulmonary hypertension 2 years after pulmonary embolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008


Pulmonary embolism and the consequences for the right heart
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136
Year: 2006

Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010


Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (3) 1801805; 10.1183/13993003.01805-2018
Year: 2019



Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010



Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020